Top Banner
Information Call for Funding Opportunity Announcement CDC- RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen Christie Deputy Branch Chief Field Services and Evaluation Branch National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination
43

Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Dec 16, 2015

Download

Documents

Jacoby Towler
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Information Call for Funding Opportunity Announcement CDC-

RFA-PS15-1501

Tuberculosis Elimination and Laboratory Cooperative

AgreementJuly 10, 2014

Glen ChristieDeputy Branch Chief

Field Services and Evaluation Branch

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB PreventionDivision of Tuberculosis Elimination

Page 2: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Agenda

Goals and objectives

FOA amendments

FOA Background & overview of approach

Prevention & Control, Human Resource Development, and PH Laboratory strengthening components

Program evaluation

Award information and eligibility

Application submission & reporting requirements

Application review process

Q&A session

Page 3: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Goal and Objective

Goal: Provide an opportunity for eligible applicants to receive assistance with the application process for CDC-RFA-PS15-1501

Objective: Provide an overview of the content of the Funding Opportunity Announcement (FOA) and the application submission process

Page 4: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

FOA AmendmentsFOA Section Justification

CDC Project Description (Outcomes)

Provide link to the current national TB program objectives and performance targets

CDC Project Description (Funding Strategy)

Incorporate a more narrow funding range for anticipated awards for P&C, HRD, and Lab in BP1 (2015)

Strategy 5: Program Evaluation

Consistency in language on attendance to TB PEN & ETN Conferences

Collaboration (with organizations external to CDC)

Interim progress reports are not required. Information should be provided in APR

Project Narrative Clarify the page limits for each component between the project narrative and work plan

Award Information Correct the amount listed for floor of individual award range

Application & Submission (Budget Narrative)

Include expectation for attendance at annual National TB Conference

Page 5: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

FOA Amendments (cont’d)

The amended FOA will be published after the Laboratory information call on July 14, 2014

FOA Section Justification

Application & Submission (Budget Narrative)

Provide clarification on the P&C budget submission

Application & Submission (Budget Narrative

Clarify that contract methods are not needed for RTMCC services

Application & Submission (Organizational Capacity)

Clarify requirement for CVs/resumes for key personnel

Page 6: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

FOA Background

FOA authorized under Section 317E of the PHS Act

Continues a 30-year strategy of federal support to complement state & local TB prevention & control activities and laboratory services

Provide funds to support TB P&C, HRD, and laboratory services based on a data-driven formula developed in collaboration with NTCA

Beginning in 2015, 100% of P&C and HRD funds allocated according to the case-based formula

Lab funds for each jurisdiction determined according to workload-based formula

Page 7: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

FOA Approach The goal is to reduce morbidity and

mortality caused by TB. This section contains: Description of why TB is a problem worth addressing

through the FOA

The stated purpose for the prevention, control, and elimination of TB

A logic model outlining the short term, intermediate, and long term outcomes for the 5-year project period

The strategy for awarding funds through the CoAg.

• Note the change for applicants to submit “true needs” budget for P&C and lab that anticipates cost for operations, program improvement, and potential emergencies

Page 8: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Strategies and Activities FOA adopts a priority-based approach for

P&C and list the activities to complete under the three priorities identified on page 9

TB programs should accomplish priority activities based on the tier they belong to

TB programs are assigned to tiers based on number of cases reported each year

Tier 1: ≤ 50 cases annually

Tier 2: 51-500 cases annually

Tier 3: >500 cases annually

Page 9: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Organizational Capacity and Collaboration

Guidance on demonstrating organizational capacity to execute the strategies and activities is provided on page 20

FOA describes the expectation for collaborating with other CDC funded programs as well as organizations external to CDC on pages 15-16

Both required partnerships and recommended collaborations are identified

Page 10: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

TB Prevention and Control

Andrew Heetderks, MPHTeam Lead

Field Services and Evaluation Branch

Page 11: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Strategies and Activities

Largely the same as from previous COAGs

Found on the Logic model columns 1 & 2

Also enumerated pages 8 - 13 in the FOA

Find your tier and then describe activities which your program intends to employ

These strategies and activities should be justified by the budget

Page 12: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Tiers There are three tiers, broken down by

morbidity

Programs are expected at minimum to perform the activities listed in their tier

Programs may utilize additional activities than found in their tier, but must be vigilant to pursue completion of all their tier priorities first

Tier 1/Priority 1 strategies and activities are cross-cutting and appropriate for all – this includes those for PE, HRD and Lab

Page 13: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

What’s New

Large outbreak surveillance (tier 1)

Targeted testing among those with diabetes or other NCDs (tier 3)

Each grantee will designate at least one liaison for locally determined high-risk populations (e.g. homeless, corrections) and provide brief summary reports of activities to address TB control in these populations

Health Equity: enhancing collaboration and coordination of health disparities activities

Page 14: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Important notes

Do follow instructions in the FOA – all is in there for you to submit a complete application

Don’t forget to describe your program’s capacity to perform essential TB P&C services found under “Organizational Capacity of Awardees to Execute the Approach”

Page 15: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Work plan

Overall, programs should develop and provide a work plan and implementation plan with elements supporting the scope of their activities in relationship to TB control program strategies and target populations.

Pay attention to page limits

Work plan/Narrative 30 pages

Page 16: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

CDC Program Support Listed in separate section

TA, guidance, coordination and programmatic consultation

Will identify and establish priority for training needs

Will help identify and notify areas about large outbreaks and assess needs for supplemental assistance

Will collaborate to compile and publish accomplishments and lessons learned

Page 17: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Human Resource Development

Wanda Walton, PhD, MEdBranch Chief

Communications, Education, and Behavioral Studies Branch

Page 18: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Human Resource Development

Priority 1 Activity - Ensure appropriate training, education, and other human resource development (HRD) activities

Page 19: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Strategy 6: Human Resource Development

(HRD)Recipient requirements:

Designate person to serve as focal point for training within the TB program.

Ensure designee is active participant in TB Education and Training Network (TB ETN).

Develop Training/Human Resource Development (HRD) Plan based on program needs.

Provide line-item budget to specify how funds will be used to achieve objectives and activities.

Provide yearly update of progress-to-date on HRD activities.

Page 20: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Areas of Responsibility for TB Education and Training Focal

Points Serve as primary contact in their respective

TB program for DTBE and RTMCC education and training activities, including needs assessments, capacity building, and resource development/sharing.

Ensure development and implementation of an annual Training and HRD Plan specific to their TB program (example provided in FOA).

Provide annual update of progress-to-date on HRD plan activities, i.e., Annual HRD Progress Report.

Coordinate development and implementation of subsequent annual HRD plans.

Page 21: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Human Resource Development (HRD)

Training and HRD Plan

The work plan must include an annual training and HRD plan that describes how activities will be executed to achieve the objectives identified under the “Strategies and Activities” in section A (2.v.) of the FOA.

Page 22: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Develop Annual Training and HRD Plan to:

Establish and improve existing in-service TB training and human resource development.

Establish evaluation strategies to improve existing systems and to identify ongoing training and human resource development needs.

Establish and improve patient education and communications capacity within the TB program.

Coordinate training related to TB control with training for other disease control interventions, such as HIV/AIDS, viral hepatitis, and STD.

Target other health care providers or organizations serving high-risk populations.

Page 23: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Laboratory Component

Angela M. Starks, PhDBranch Chief

Laboratory Branch, Division of Tuberculosis Elimination

Page 24: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Strategy 7: Public Health Laboratory Strengthening

Tier 1 activity Laboratory Component consists of 3

elements described beginning on page 22 of FOA1)Availability of high quality and prompt

laboratory services2)Continual advancement of laboratory

efficiency and quality assurance through use of local data

3)Collaboration with partners to ensure optimal use of services and timely flow of information

Page 25: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Volume Considerations for Laboratory Elements

Tiers Based on Volume Work Plan Requirement

1. <2,000 clinical specimens/ year

2. 2,001–6,000 clinical specimens/ year

3. >6,000 clinical specimens/ year

Tier 1- Provide one measurable outcome associated with strategy and activitiesTier 2- Provide two measurable outcomesTier 3- Provide three measurable outcomes

Element 1 All laboratories, regardless of volume, should

describe anticipated outcomes and specific strategies and activities for achieving outcomes

Element 2 and 3 Different level of required activities based on

volume Parallel to P&C tiered approach Consideration for differences in level of funding,

staff, and capacity to support activities

Page 26: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Laboratory Specific Funding Restriction

Laboratories performing first-line drug susceptibility testing for < 50 patient isolates/ year should refer isolates to a higher volume reference laboratory for testing. (http://www.aphl.org/aphlprograms/infectious/tuberculosis/Documents/ID_2007Dec_TB-DST-Report.pdf )

As such, laboratories reporting, as part of this application, DST for < 50 patient isolates/ year may not request funding support for reagents and supplies associated with conventional DST.

Laboratories within this category may request the use of funds for shipping supplies and costs for access to referral services.

Page 27: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Program Evaluation

Awal Khan, PhDTeam Lead

Field Services and Evaluation Branch

Page 28: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Program Logic Model

Program Evaluation (PE)

Increase partnership & collaboration for PE plan and implementation with designated PE focal point person

Increase shared learning of PE activities & adoption for improvement in alignment with needs/priorities

Identify best practices & intent to act on sustainable TB P&C efforts by adopting new knowledge

Page 29: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Strategies and Activities Clear expectation(s) of PE Greater consistency in PE practices Standardized approaches and processes to

PE Standardized PE report Bridging PE implementation gaps PE plan is in alignment of program strategic

objectives and needs Establish infrastructure that allows

continuous & sustainable program improvement

Results in improvement in program operation & management

Page 30: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Work Plan

Priority levels and target populations Framework – PE questions, indicators,

methods, etc. Collective responsibility and mutual

accountability Communication & using PE findings Actions taken from recommendations Ongoing learning and capacity building Focus on effectiveness along with efficiency Focus on performance management Grantees have autonomy in selecting PE

focus area

Page 31: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Performance Measures

National TB program objectives New measures for formative/process

evaluation Measures of engagement/partnership

strategies Communication mechanisms for PE findings Identifying best practices from PE findings Sustainability of impact – actions are taken

from recommendations FSEB/PET is ready to provide TA as needed

Page 32: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Award Information and Eligibility

Glen Christie, MPHDeputy Branch Chief

Field Services and Evaluation Branch

Page 33: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Award Information and Eligibility

Approximate funded levels listed under award information on page 27 are based on availability of funds

Applicant eligibility and the justification for limited competition did not change from the current CoAg

Page 34: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Application Submission Process & Reporting Requirements

Andrew Heetderks, MPHTeam Lead

Field Services and Evaluation Branch

Page 35: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Application Submission Process & Reporting Requirements

These items are typically covered by PGO in standard language. Application package can be found at www.grants.gov

Applicants may email or call CDC PGO staff for assistance (770) 488-2700 or [email protected]

Application deadline August 20, 2014 at 11:59 p.m. Eastern time.

Page 36: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Application Submission

As a multicomponent FOA, you have a total of 30 pages – excluding budget. Please respond to all headings!

Please bold each heading shown in the information submission section.

Applicants must prepare and upload the files identified in FOA as a PDF file at www.grants.gov

Budget requirements are consistent with previous years

Applicants should submit a true needs budget to include costs associated with outbreak response.

Applicants must upload their budgets as a PDF file at www.grants.gov

Page 37: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Reporting Requirements Evaluation and Performance Measurement

Plan Within first 6 months of the project period No more than 25 pages Required content identified in FOA

Annual Performance Report (APR) Not to exceed 45 pages excluding admin reporting;

attachments not allowed, but web links are Submit via www.grants.gov 120 days before end of

budget period APR replaces Annual progress Report and Interim

Progress Report Information serve purpose of both report on

performance measure and application for continued funding

Page 38: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Annual Performance Report The APR should cover each budget period

(BP) throughout the 5-year project period as follows: In BP 2015, the APR will be due August 31 for

the activities performed January 1, 2015 through June 30, 2015.

For BPs 2016–2019, APRs will be due on August 31 of each year and cover the prior calendar year (January 1–December 31) and also an update of activities/ strategies and outcomes achieved during the first 6 months (January 1–June 30) of the current year.

Data and associated information should be stratified by budget year (i.e., do not report as a single 18 month period).

Page 39: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Reporting Requirements

Performance Measure Reporting

Annual Performance Reports meet this annual requirement

CDC may request additional report in certain instances such as a jurisdiction’s response to large TB outbreaks

Minimum content of report identified in FOA

Submit 90 days following response to large outbreaks and quarterly thereafter for the first year of outbreak response, and at least semiannually thereafter until the outbreak subsides

Page 40: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Application review Phase I:

Done by PGO and DTBE for completeness and eligibility

Phase II: DTBE will perform structured technical reviews

on criteria and budget sections found in the FOA

Rating criteria assigned to sections under Approach, Evaluation and Performance Management, and Organizational Capacity

CDC PGO staff will review for all assurance and certification forms

Page 41: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Questions?

Page 42: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Additional Questions

Submit to FOA mailbox at [email protected] Recording of FOA information call will be

made available FAQ document will be updated and

distributed

Page 43: Information Call for Funding Opportunity Announcement CDC-RFA-PS15-1501 Tuberculosis Elimination and Laboratory Cooperative Agreement July 10, 2014 Glen.

Call Adjourned